Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VHL | P40337 | 1/20 | 0.51 |
| ▸ | ACE | P12821 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630642 | 0.84 | OPRM1 (0.49) | ACEOPRM1OPRD1SLC6A2 | |
| SCHEMBL16925966 | 0.81 | VHL (0.52) | VHLOPRM1OPRD1 | |
| SCHEMBL19381670 | 0.81 | VHL (0.52) | VHLOPRM1OPRD1 | |
| SCHEMBL29373528 | 0.81 | VHL (0.52) | VHLOPRM1OPRD1 | |
| SCHEMBL16925967 | 0.81 | VHL (0.49) | VHLOPRM1OPRD1SLC6A2 | |
| SCHEMBL31265374 | 0.80 | CHRM3 (0.44) | — | |
| SCHEMBL31265371 | 0.79 | CHRM2 (0.41) | VHLACE | |
| SCHEMBL30862234 | 0.79 | SLC6A2 (0.54) | ACEOPRM1OPRD1SLC6A2 | |
| SCHEMBL31267118 | 0.78 | ITGB1 (0.54) | ACEOPRM1OPRD1SLC6A2 | |
| SCHEMBL31683331 | 0.78 | OPRD1 (0.52) | OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120118177-A | Preparation method of fish collagen peptide and application of fish collagen peptide in improving skin aging | 广州市缇梵化妆品有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-120118177-A | Preparation method of fish collagen peptide and application of fish collagen peptide in improving skin aging | 广州市缇梵化妆品有限公司 | 2025-06-10 | — | — | CN | disclosed |